Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2026 30 April
Multiple Ivonescimab Data Sets from Phase III Studies in Advanced NSCLC Patient Populations to be Featured at ELCC 2026 27 March
Summit Therapeutics Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 2025 23 February
